GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bangkok Genomics Innovation PCL (BKK:BKGI) » Definitions » Stock Based Compensation

Bangkok Genomics Innovation PCL (BKK:BKGI) Stock Based Compensation : ฿0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Bangkok Genomics Innovation PCL Stock Based Compensation?

Bangkok Genomics Innovation PCL's Stock Based Compensation for the three months ended in Mar. 2025 was ฿0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ฿0.0 Mil.


Bangkok Genomics Innovation PCL Stock Based Compensation Historical Data

The historical data trend for Bangkok Genomics Innovation PCL's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bangkok Genomics Innovation PCL Stock Based Compensation Chart

Bangkok Genomics Innovation PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial - - - - -

Bangkok Genomics Innovation PCL Quarterly Data
Dec19 Dec20 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bangkok Genomics Innovation PCL Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.0 Mil.


Bangkok Genomics Innovation PCL Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Bangkok Genomics Innovation PCL's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bangkok Genomics Innovation PCL Business Description

Traded in Other Exchanges
N/A
Address
3689 Rama 4 Road, Phra Khanong Subdistrict, Khlong Toei Subdistrict, Bangkok, THA, 10110
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Scientific testing services which generates key revenue, and Sale of goods.

Bangkok Genomics Innovation PCL Headlines